Marein alleviates the development of atherosclerosis through targeting miR ‐126/lipoprotein‐associated phospholipase A 2 axis
The FASEB Journal · 15.02.2025 · 39 (3)
DOI: 10.1096/fj.202402378r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 08.02.2025. Verfasst von Lisha Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Zhongshan City People's Hospital, Zhongshan, China. Hauptthemen laut MEDLINE: MicroRNAs, Atherosclerosis, 1-Alkyl-2-acetylglycerophosphocholine Esterase, Chalcones. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: General research project of inheritance and innovation of Traditional Chinese Medicine and development of Zhongshan city.
Abstract (Originalsprache)
As a classical precious medicine, Coreopsis tinctoria Nutt. ( C. tinctoria ) is widely utilized for treatment of cardiometabolic diseases, while the important compound of C. tinctoria , marein exhibits multiple beneficial biological effects that related to the pathophysiological processes underlying atherogenesis. Thus, the purpose of present study is to investigate the role of marein on the development of atherosclerosis. In the current study, we observed that marein exhibited anti‐inflammatory response function verified by reduced mRNA and protein levels of classical M1 but enhanced alternative M2 macrophage genes. Moreover, marein dramatically attenuated macrophage‐induced foam cell formation with up‐regulated cholesterol efflux but down‐regulated cholesterol influx‐related genes expression in bone marrow‐derived macrophage (BMDMs) administrated with oxidized low‐density lipoprotein (Ox‐LDL), observed by staining with Oil‐Red O, RT‐PCR, or western blot analysis. Treatment of ApoE knockout mice (ApoE −/− ) with marein at indicated time which consistently fed with high‐fat diet for 12 weeks was utilized to explore the function of marein on atherogenesis in vivo. We revealed that marein‐treated group alleviated atherosclerotic plaques in the entire aorta and aortic root and inhibited plaque vulnerability characterized by decreased necrotic core, reduced macrophage, and lipid accumulation, whereas increased fibrous cap, enhanced smooth muscle cell, and collagen deposition. Importantly, we noticed that miR‐126 could target to lipoprotein‐associated phospholipase A 2 (Lp‐PLA 2 ), and enhanced miR‐126 but reduced Lp‐PLA 2 expression was responsible for the alleviated function of marein on macrophage dysfunction. Collectively, we identified that marein could be a promising drug for prevention of the development of atherosclerosis by protecting against macrophage‐mediated foam cell formation and inflammation, partially through miR‐126/Lp‐PLA 2 dependent mechanism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Zhongshan City People's Hospital, Zhongshan, China.
- Pharmaceutical Laboratory, Institute of Materia Medica of Xinjiang Uygur Autonomous Region, Xinjiang, China.
- College of Life Sciences and Technology, Xinjiang University, Xinjiang, China.
- Center for Food and Drug Evaluation and Inspection, The Xinjiang Production and Construction Corps, Xinjiang, China.
ORCID-Profile: Weiguo Zhao
Förderung
- General research project of inheritance and innovation of Traditional Chinese Medicine and development of Zhongshan city
Zitieren
APA
Zhao, L., Xing, J., Wang, Y., Xin, L., Cheng, X., Chen, Y., Wang, P., Zhang, L., & Zhao, W. (2025). Marein alleviates the development of atherosclerosis through targeting miR ‐126/lipoprotein‐associated phospholipase A 2 axis. The FASEB Journal, 39(3). https://doi.org/10.1096/fj.202402378r
Vancouver
Zhao L, Xing J, Wang Y, Xin L, Cheng X, Chen Y, et al. Marein alleviates the development of atherosclerosis through targeting miR ‐126/lipoprotein‐associated phospholipase A 2 axis. The FASEB Journal. 2025;39(3). doi:10.1096/fj.202402378r
BibTeX
@article{Zhao2025,
author = {Zhao, Lisha and Xing, Jie and Wang, Yunfei and Xin, Ling and Cheng, Xiaorong and Chen, Yanying and Wang, Panpan and Zhang, Lanlan and Zhao, Weiguo},
title = {Marein alleviates the development of atherosclerosis through targeting miR ‐126/lipoprotein‐associated phospholipase A 2 axis},
journal = {The FASEB Journal},
year = {2025},
volume = {39},
number = {3},
doi = {10.1096/fj.202402378r}
}
EUVIMED